Are Ubiquitination Pathways Central to Parkinson's Disease?
- 1 July 2003
- Vol. 114 (1) , 1-8
- https://doi.org/10.1016/s0092-8674(03)00509-9
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Parkin Protects against the Toxicity Associated with Mutant α-SynucleinNeuron, 2002
- Phosphorylated α-Synuclein Is Ubiquitinated in α-Synucleinopathy LesionsJournal of Biological Chemistry, 2002
- The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease SusceptibilityCell, 2002
- Animal Models of PDNeuron, 2002
- Complex relationship between Parkin mutations and Parkinson diseaseAmerican Journal of Medical Genetics, 2002
- α‐Synuclein metabolism and aggregation is linked to ubiquitin‐independent degradation by the proteasomeFEBS Letters, 2001
- Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's DiseaseScience, 2001
- Alpha-synuclein and neurodegenerative diseasesNature Reviews Neuroscience, 2001
- Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase ActivityJournal of Biological Chemistry, 2000
- Recognition of the polyubiquitin proteolytic signalThe EMBO Journal, 2000